GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » Inventories, Other

ENCell Co (XKRX:456070) Inventories, Other : ₩-0 Mil (As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is ENCell Co Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. ENCell Co's other inventories for the quarter that ended in Dec. 2023 was ₩-0 Mil.

ENCell Co's quarterly other inventories stayed the same from Dec. 2021 (₩0 Mil) to Dec. 2022 (₩0 Mil) but then declined from Dec. 2022 (₩0 Mil) to Dec. 2023 (₩-0 Mil).

ENCell Co's annual other inventories stayed the same from Dec. 2021 (₩0 Mil) to Dec. 2022 (₩0 Mil) but then declined from Dec. 2022 (₩0 Mil) to Dec. 2023 (₩-0 Mil).

ENCell Co Inventories, Other Historical Data

The historical data trend for ENCell Co's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENCell Co Inventories, Other Chart

ENCell Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Inventories, Other
- - - -

ENCell Co Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Inventories, Other - - - -

ENCell Co Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

ENCell Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » Inventories, Other
Comparable Companies
Traded in Other Exchanges
N/A
Address
701 Yeongdong-daero, 11th floor, Gangnam-gu, Seoul, KOR
Website
http://www.encellinc.com
ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.

ENCell Co Headlines

No Headlines